Purchase Order HHSN272201200717P

Award Date 8/15/12
Potential Completion Date 11/30/12
Potential Value $8.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Birmingham, AL 35255, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $544,000.00 cost-plus-fixed-fee definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, to Southern Research Institute, a corporate entity tax-exempt non-profit organization. The contract is for biomedical (applied/exploratory) research and does not have a set-aside designation. Through this contract, Southern Research Institute is providing a range of services, including drug discovery and...
This is a definitive cost-plus-fixed-fee contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Southern Research Institute for AIDS research (basic). The contract has a ceiling value of $1,671,943.00 and a period of performance through January 31, 2010. Southern Research Institute is a corporate entity tax-exempt non-profit organization that offers a range of research and development services, including drug...
This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Southern Research Institute, a corporate entity tax-exempt non-profit organization. The contract is a delivery order under the NIAID Animal Models of Infectious Diseases 2010-2017 Indefinite Delivery/Indefinite Quantity (IDIQ) contract vehicle. The contract has a ceiling value of $1,077,795.08 and is a cost-plus-fixed-fee type. The contract does not have a set-aside...
This is a firm fixed price delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, to Southern Research Institute. The order is part of the In Vitro Antimicrobial Assessments 2011-2018 indefinite delivery/indefinite quantity (IDIQ) contract vehicle, valued at a ceiling of $410,090.00. The order is for in vitro antimicrobial assessment services, with a period of performance through February 28, 2013. Southern Research...
This is a definitive cost-plus-fixed-fee contract awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Southern Research Institute, a corporate entity tax-exempt non-profit organization, for research and development in the physical sciences. The contract has a potential value of $12,649,161.00 and was awarded on April 1, 2001 with a completion date of July 15, 2006. The contract is not set aside. Southern Research Institute has provided a...
This is a $101,416.55 firm fixed price delivery order awarded to Southern Research Institute by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH). The order is for Task A04 - In Vitro Screening for Antibacterial Activity under NIAID's In Vitro Antimicrobial Assessments 2011-2018 indefinite delivery/indefinite quantity (IDIQ) contract. The order has a completion date of July 31, 2013. Southern Research Institute is a non-profit research...
This federal contract award, with a ceiling value of $219,100.00, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency of the U.S. government, to Southern Research Institute, a corporate entity tax-exempt non-profit organization. The contract is for "IN VITRO ASSESSMENTS FOR ANTIMICROBIAL ACTIVITY" and is a delivery order under a larger Indefinite Delivery/Indefinite Quantity (IDIQ) contract vehicle called "In Vitro Antimicrobial...
This firm fixed-price delivery order contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services (HHS), to Southern Research Institute, a non-profit research organization. The contract, valued at $26,480.00, is for "IN VITRO ASSESSMENTS FOR ANTIMICROBIAL ACTIVITY" and was awarded under the "In Vitro Antimicrobial Assessments 2011-2018" indefinite delivery/indefinite...
This is a $37,522 Firm Fixed Price delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Southern Research Institute, a corporate entity tax-exempt non-profit organization. The contract is to provide in vitro assessment for antimicrobial activity, and is part of the broader In Vitro Antimicrobial Assessments 2011-2018 IDIQ contract vehicle. Southern Research Institute has extensive experience providing research and development...
This is a federal contract award to Southern Research Institute, a non-profit organization, by the National Institute of Allergy and Infectious Diseases (NIAID) under the Department of Health and Human Services (HHS). The contract has a ceiling value of $26,986,655.00 and was awarded on September 15, 2003 with a period of performance through September 29, 2010. The contract is a Definitive Contract with a Cost Plus Fixed Fee pricing type. Southern Research Institute, also known as Southern...

This is a $8,755.00 firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Southern Research Institute, a non-profit research organization. The contract has no set-aside designation and was awarded on August 15, 2012, with a completion date of November 30, 2012. Southern Research Institute, doing business as Southern Research, has experience providing drug discovery and development, infectious disease research, and other scientific services to federal agencies including NIH, CDC, DoD, and EPA through past prime and subcontract awards. This specific contract appears to be part of NIAID's broader acquisition programs focused on advancing medical countermeasures and research related to emerging infectious diseases.

Generated 11/24/24, 9:07 AM